DDTL
gene geneOn this page
Summary
DDTL (D-dopachrome tautomerase like, HGNC:33446) is a protein-coding gene on chromosome 22q11.23, encoding Putative D-dopachrome decarboxylase-like protein (A6NHG4). May have a carboxy-lyase activity.
Predicted to enable phenylpyruvate tautomerase activity. Located in extracellular exosome.
Source: NCBI Gene 100037417 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 7 total — 1 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_001084393
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33446 |
| Approved symbol | DDTL |
| Name | D-dopachrome tautomerase like |
| Location | 22q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000099974 |
| Ensembl biotype | protein_coding |
| Entrez | 100037417 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000215770, ENST00000897122
RefSeq mRNA: 1 — MANE Select: NM_001084393
NM_001084393
CCDS: CCDS42988
Canonical transcript exons
ENST00000215770 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001493396 | 23971286 | 23972556 |
| ENSE00001661823 | 23966888 | 23967022 |
| ENSE00001678640 | 23967386 | 23967561 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 93.20.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.6200 / max 100.4801, expressed in 1807 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 209420 | 12.6200 | 1807 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 93.20 | gold quality |
| liver | UBERON:0002107 | 89.03 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.97 | gold quality |
| body of pancreas | UBERON:0001150 | 85.14 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.64 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 83.77 | gold quality |
| apex of heart | UBERON:0002098 | 83.42 | gold quality |
| metanephros cortex | UBERON:0010533 | 82.59 | gold quality |
| cortex of kidney | UBERON:0001225 | 81.90 | gold quality |
| fundus of stomach | UBERON:0001160 | 81.43 | gold quality |
| body of stomach | UBERON:0001161 | 81.11 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 80.24 | gold quality |
| transverse colon | UBERON:0001157 | 80.06 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 79.55 | gold quality |
| heart left ventricle | UBERON:0002084 | 78.98 | gold quality |
| stomach | UBERON:0000945 | 78.89 | gold quality |
| small intestine | UBERON:0002108 | 78.86 | gold quality |
| rectum | UBERON:0001052 | 78.75 | gold quality |
| prostate gland | UBERON:0002367 | 78.63 | gold quality |
| pancreas | UBERON:0001264 | 78.21 | gold quality |
| kidney | UBERON:0002113 | 78.19 | gold quality |
| spleen | UBERON:0002106 | 77.98 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.97 | gold quality |
| blood | UBERON:0000178 | 77.84 | gold quality |
| esophagus mucosa | UBERON:0002469 | 77.57 | gold quality |
| intestine | UBERON:0000160 | 77.47 | gold quality |
| endometrium | UBERON:0001295 | 77.47 | gold quality |
| left ovary | UBERON:0002119 | 77.47 | gold quality |
| colon | UBERON:0001155 | 77.27 | gold quality |
| duodenum | UBERON:0002114 | 76.99 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9543 | yes | 39.04 |
| E-ANND-3 | yes | 9.23 |
| E-CURD-112 | yes | 7.21 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
46 targeting DDTL, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-1272 | 99.34 | 68.79 | 878 |
| HSA-MIR-4685-5P | 99.25 | 65.99 | 1563 |
| HSA-MIR-6837-5P | 99.25 | 65.47 | 1632 |
| HSA-MIR-4528 | 99.18 | 69.77 | 1936 |
| HSA-MIR-548L | 99.06 | 70.90 | 2560 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-3938 | 98.72 | 66.07 | 834 |
| HSA-MIR-31-5P | 98.58 | 68.35 | 1239 |
| HSA-MIR-5187-5P | 98.54 | 67.94 | 952 |
| HSA-MIR-4266 | 98.53 | 67.29 | 1035 |
Literature-anchored findings (GeneRIF, showing 2)
- Authors performed genetic case-control CNV analyses to test for possible associations between schizophrenia and CNVs for the three genes GSTT1, DDTL, and GSTM1 in Japanese patients. (PMID:26175060)
- Genetic regulation of gene expression of MIF family members in lung tissue. (PMID:33046825)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ddt | ENSDARG00000044751 |
| mus_musculus | Ddt | ENSMUSG00000001666 |
| rattus_norvegicus | ENSRNOG00000083406 |
Paralogs (2): DDT (ENSG00000099977), MIF (ENSG00000240972)
Protein
Protein identifiers
Putative D-dopachrome decarboxylase-like protein — A6NHG4 (reviewed: A6NHG4)
Alternative names: D-dopachrome tautomerase-like protein
All UniProt accessions (2): A6NHG4, A0A0F7RPW6
UniProt curated annotations — full annotation on UniProt →
Function. May have a carboxy-lyase activity.
Subcellular location. Cytoplasm.
Similarity. Belongs to the MIF family.
RefSeq proteins (1): NP_001077862* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001398 | Macrophage_inhib_fac | Family |
| IPR014347 | Tautomerase/MIF_sf | Homologous_superfamily |
| IPR019829 | Macrophage_inhib_fac_CS | Conserved_site |
Pfam: PF01187
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NHG4-F1 | 73.43 | 0.32 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY, GOMF_ISOMERASE_ACTIVITY, MIR4500, MIR548L, LET_7B_5P, LET_7A_5P_LET_7C_5P_LET_7E_5P, LET_7I_5P, LET_7F_5P, LET_7G_5P, MIR98_5P, MIR4534, MIR4678, MIR331_5P, DESCARTES_MAIN_FETAL_HEMATOPOIETIC_STEM_CELLS, DESCARTES_FETAL_KIDNEY_LYMPHOID_CELLS
GO Biological Process (0):
GO Molecular Function (2): lyase activity (GO:0016829), phenylpyruvate tautomerase activity (GO:0050178)
GO Cellular Component (3): obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737), extracellular exosome (GO:0070062)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| catalytic activity | 1 |
| intramolecular oxidoreductase activity, interconverting keto- and enol-groups | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
284 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DDTL | GSTT4 | A0A1W2PR19 | 646 |
| DDTL | GSTT2B | P0CG30 | 570 |
| DDTL | LRRC75B | Q2VPJ9 | 542 |
| DDTL | C22orf15 | Q8WYQ4 | 507 |
| DDTL | ATP5MGL | Q7Z4Y8 | 433 |
| DDTL | RIMBP3B | A6NNM3 | 417 |
| DDTL | DRICH1 | Q6PGQ1 | 417 |
| DDTL | SLC35E4 | Q6ICL7 | 396 |
| DDTL | GUCD1 | Q96NT3 | 371 |
| DDTL | CCNI2 | Q6ZMN8 | 370 |
| DDTL | TMEM121B | Q9BXQ6 | 350 |
| DDTL | RIMBP3C | A6NJZ7 | 349 |
| DDTL | H7C1H1 | H7C1H1 | 348 |
| DDTL | ZNF70 | Q9UC06 | 348 |
| DDTL | SLC2A11 | Q9BYW1 | 337 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM24 | DDTL | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (17): TRIM24 (Affinity Capture-MS), ARHGDIA (Affinity Capture-MS), MTPN (Affinity Capture-MS), MDH1 (Affinity Capture-MS), TBCA (Affinity Capture-MS), CYCS (Affinity Capture-MS), CSTB (Affinity Capture-MS), RPS28 (Affinity Capture-MS), DDTL (Proximity Label-MS), DDTL (Proximity Label-MS), DDTL (Affinity Capture-MS), DDTL (Cross-Linking-MS (XL-MS)), DDTL (Proximity Label-MS), XPO1 (Co-fractionation), PPP2CA (Co-fractionation)
ESM2 similar proteins: A0A142I740, A2QM49, A5PK65, A6NHG4, A9SDL4, A9V2Y9, B2RXM4, B4G653, C5WU23, D3ZVR1, D4AWH0, D7PHZ1, F7D4X9, G0R6S7, K2RU68, O35215, O95755, O96347, P0DO34, P30046, P30111, P80254, P90835, P9WEP2, Q08CY5, Q0CS96, Q0DDI1, Q0IHU5, Q11177, Q18785, Q25313, Q28J83, Q4WQZ6, Q567W6, Q59750, Q5AXB0, Q5MFW3, Q5PQA5, Q5VVY1, Q5ZC83
Diamond homologs: A5PK65, A6NHG4, O35215, O55052, P14174, P30046, P80177, P80254, P80928, P81529, P91850, Q1ZZU7, Q28J83, Q4R549, Q5ZMG0, Q640C5, Q68FI3, Q6DN04, A9JSE7, P30904, P34884, Q02960, Q18785, O44786, P81748, Q76BK2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
7 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 253435 | GRCh37/hg19 22q11.22-11.23(chr22:23258229-25046803)x3 | Pathogenic |
| 635766 | GRCh37/hg19 22q11.22-11.23(chr22:22998284-25119103)x3 | Likely pathogenic |
SpliceAI
382 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:23967019:GGAC:G | donor_gain | 1.0000 |
| 22:23967020:G:GT | donor_gain | 1.0000 |
| 22:23967020:GAC:G | donor_gain | 1.0000 |
| 22:23967023:G:GG | donor_gain | 1.0000 |
| 22:23967018:CGGAC:C | donor_gain | 0.9900 |
| 22:23967019:GGACG:G | donor_gain | 0.9900 |
| 22:23967020:G:T | donor_gain | 0.9900 |
| 22:23967020:GACG:G | donor_loss | 0.9900 |
| 22:23967021:AC:A | donor_gain | 0.9900 |
| 22:23967021:ACGTA:A | donor_loss | 0.9900 |
| 22:23967022:CGTAA:C | donor_loss | 0.9900 |
| 22:23967023:GTAA:G | donor_loss | 0.9900 |
| 22:23967024:T:TG | donor_loss | 0.9900 |
| 22:23967385:GC:G | acceptor_gain | 0.9900 |
| 22:23967385:GCGC:G | acceptor_gain | 0.9900 |
| 22:23967522:T:TG | donor_gain | 0.9900 |
| 22:23967539:G:GT | donor_gain | 0.9900 |
| 22:23967562:G:GG | donor_gain | 0.9800 |
| 22:23967563:TGC:T | donor_loss | 0.9800 |
| 22:23967564:GCG:G | donor_loss | 0.9800 |
| 22:23967573:T:TA | donor_gain | 0.9800 |
| 22:23967574:A:AA | donor_gain | 0.9800 |
| 22:23967027:GC:G | donor_gain | 0.9700 |
| 22:23967384:A:AG | acceptor_gain | 0.9700 |
| 22:23967385:G:GG | acceptor_gain | 0.9700 |
| 22:23967522:T:G | donor_gain | 0.9700 |
| 22:23967557:G:GT | donor_gain | 0.9700 |
| 22:23967566:G:C | donor_loss | 0.9700 |
| 22:23967380:CCTCA:C | acceptor_loss | 0.9600 |
| 22:23967381:CTCA:C | acceptor_loss | 0.9600 |
AlphaMissense
856 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:23966941:T:A | N9K | 0.968 |
| 22:23966941:T:G | N9K | 0.968 |
| 22:23967013:A:C | K33N | 0.955 |
| 22:23967013:A:T | K33N | 0.955 |
| 22:23967387:G:C | R37P | 0.950 |
| 22:23966921:T:C | F3L | 0.949 |
| 22:23966923:C:A | F3L | 0.949 |
| 22:23966923:C:G | F3L | 0.949 |
| 22:23967396:T:A | V40E | 0.944 |
| 22:23967462:T:A | I62N | 0.941 |
| 22:23966994:C:A | A27D | 0.940 |
| 22:23966919:C:A | P2Q | 0.926 |
| 22:23967450:C:A | A58E | 0.925 |
| 22:23967527:T:C | F84L | 0.923 |
| 22:23967529:T:A | F84L | 0.923 |
| 22:23967529:T:G | F84L | 0.923 |
| 22:23966982:T:A | L23H | 0.915 |
| 22:23966931:T:A | L6Q | 0.914 |
| 22:23967011:A:G | K33E | 0.914 |
| 22:23967390:T:A | V38E | 0.910 |
| 22:23967405:G:C | R43P | 0.904 |
| 22:23967462:T:G | I62S | 0.903 |
| 22:23967521:T:C | F82L | 0.902 |
| 22:23967523:T:A | F82L | 0.902 |
| 22:23967523:T:G | F82L | 0.902 |
| 22:23967012:A:T | K33I | 0.899 |
| 22:23967528:T:C | F84S | 0.897 |
| 22:23967402:T:A | V42E | 0.896 |
| 22:23967012:A:C | K33T | 0.895 |
| 22:23967464:T:C | S63P | 0.895 |
dbSNP variants (sampled 300 via entrez): RS1000155777 (22:23970640 G>A,T), RS1001108851 (22:23969037 C>T), RS1001147883 (22:23969290 T>C), RS1001149768 (22:23971758 C>T), RS1001776114 (22:23970676 G>A), RS1003354064 (22:23969724 C>G), RS1004285833 (22:23969544 G>A,C), RS1005087550 (22:23972396 C>A,T), RS1005371092 (22:23965475 C>T), RS1005553864 (22:23970415 G>A), RS1005915199 (22:23970280 T>C), RS1006036899 (22:23970489 TATGAATGTCA>T), RS1006771 (22:23971817 G>T), RS1008893621 (22:23972111 T>A,C), RS1008924555 (22:23972290 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001277_19 | Liver enzyme levels (gamma-glutamyl transferase) | 2.000000e-09 |
| GCST003483_1 | S-phenylmercapturic acid levels in smokers | 3.000000e-134 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004532 | serum gamma-glutamyl transferase measurement |
| EFO:0007651 | urinary S-phenylmercapturic acid measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Rosiglitazone | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.